Phocas Financial’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
Phocas Financial's ANGO Position: Q3 2026 in Review
Phocas Financial sold out of AngioDynamics (ANGO) in Q3 2026, closing a stake of 292,510 shares — an estimated $3.81M sold.
Phocas Financial first reported a position in ANGO in Q1 2025 and held it in 6 quarters. The position peaked at $7.78M in Q4 2025. 122 funds tracked by Wall St. Rank hold ANGO as of Q3 2026.
- Phocas Financial reported no remaining AngioDynamics position as of Q3 2026 after selling out during the quarter.
- Phocas Financial sold 292,510 AngioDynamics shares in Q3 2026, an estimated $3.81M.
- Phocas Financial first reported a position in AngioDynamics in Q1 2025 and held it in 6 quarters.
- Phocas Financial's AngioDynamics position peaked at $7.78M in Q4 2025.
- 122 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2026.
Based on Phocas Financial's 13F filing for Q3 2026.